A Prospective Randomized Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS element) for the Treatment of up to Two De Novo Coronary Artery Lesions - PLATINUM Trial

ID Number 09-0201

Principal Investigator(s)
Annapoorna S. Kini

Department(s) or Division(s)
Cardiology

Description

The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. ClinicalTrials.gov Identifier: NCT00823212

Contact Information
Kameswari Vallabhajosyula
(212) 241-5696
kameswari.vallabhajosyula@msnyuhealth.org


Recruiting Patients: No